Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Pelthos Therapeutics Inc.

NYSE: PTHS · Life Sciences · 7 alerts · CIK 1919246

Share price
$7.15Close, Nov 16
Market cap
$28.1M
Shares outstanding
3.93MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Pelthos Therapeutics Inc. filings on SEC EDGAR ↗

9:18 AM ET 8-K
M&A Deal

Pelthos Therapeutics M&A Deal with Castle Creek Biosciences, Inc.

Pelthos Therapeutics has entered into a definitive agreement to acquire Castle Creek Biosciences in a merger transaction. Castle Creek stockholders will receive 5.2 million shares of Pelthos common stock plus potential milestone payments totaling up to $300 million tied to the clinical and commercial success of the D-Fi gene therapy franchise. The deal combines Pelthos' commercial dermatology infrastructure with Castle Creek's late-stage cell and gene therapy platform for rare skin diseases.

Counterparty
Castle Creek Biosciences, Inc.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.